TRANSUITE.ORG INC. (TRSO): M&A transaction — TRSO acquires 100% of AI TCM firm XRS for 10M restricted shares plus earnout

TRANSUITE.ORG INC.

TRSO issued 10M restricted shares to Hailiang Li for 100% of XRS; earnout may add shares based on 90-day valuation.
XRS combines AI social agents with Traditional Chinese Medicine; owns 300 proprietary TCM e-books and a 21-day health supervision system.
Acquisition closed Sept 30, 2025; TRSO expands into AI-powered healthcare and TCM sectors.
CEO Mengqing Fan says the deal will integrate AI and blockchain to globalize TCM products.
XRS CEO Hailiang Li expects TRSO's technology to enhance product intelligence and global expansion.

item 1.01 item 2.01 item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

TRANSUITE.ORG INC. completed an acquisition involving Crestar Holdings Limited (closed 2025-09-30).

Action: acquisition
Counterparty: Crestar Holdings Limited
Closing: 2025-09-30

Exact text from the filing

On September 30, 2025, TRSO completed the acquisition of 100% of XRS through its subsidiary Crestar.

View on SEC.gov

31 m&a transactions filed in the last 30 days. Browse all m&a transactions →

TRANSUITE.ORG INC. filing history →

Source: SEC EDGAR

accession 0001640334-25-001779

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.